Metro Valuation

Is B4B undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

3/6

Valuation Score 3/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Sales vs Peers

  • Price-To-Sales vs Industry

  • Price-To-Sales vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of B4B when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: B4B (€4.8) is trading above our estimate of fair value (€2.67)

Significantly Below Fair Value: B4B is trading above our estimate of fair value.


Key Valuation Metric

Which metric is best to use when looking at relative valuation for B4B?

Other financial metrics that can be useful for relative valuation.

B4B key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenue0.2x
Enterprise Value/EBITDA17.9x
PEG Ration/a

Price to Sales Ratio vs Peers

How does B4B's PS Ratio compare to its peers?

The above table shows the PS ratio for B4B vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PSEstimated GrowthMarket Cap
Peer Average1x
HFG HelloFresh
0.2x4.2%€1.5b
RDC Redcare Pharmacy
1.3x16.9%€2.7b
HAW Hawesko Holding
0.4x2.9%€236.3m
4162 Almunajem Foods
2x7.6%ر.س6.9b
B4B Metro
0.06x2.8%€1.7b

Price-To-Sales vs Peers: B4B is good value based on its Price-To-Sales Ratio (0.1x) compared to the peer average (1x).


Price to Earnings Ratio vs Industry

How does B4B's PE Ratio compare vs other companies in the European Consumer Retailing Industry?

0 CompaniesPrice / EarningsEstimated GrowthMarket Cap
Industry Avg.n/a10.1%
n/an/an/a
No. of CompaniesPS048121620

Fetching data

0 CompaniesPrice / EarningsEstimated GrowthMarket Cap
Industry Avg.n/a10.1%
n/an/an/a
No more companies

Price-To-Sales vs Industry: B4B is good value based on its Price-To-Sales Ratio (0.1x) compared to the European Consumer Retailing industry average (0.4x).


Price to Sales Ratio vs Fair Ratio

What is B4B's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

B4B PS Ratio vs Fair Ratio.
Fair Ratio
Current PS Ratio0.06x
Fair PS Ratio0.2x

Price-To-Sales vs Fair Ratio: B4B is good value based on its Price-To-Sales Ratio (0.1x) compared to the estimated Fair Price-To-Sales Ratio (0.2x).


Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst B4B forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
Current€4.80
€5.86
+22.2%
27.1%€9.50€4.00n/a9
Sep ’25€4.77
€5.86
+22.8%
27.1%€9.50€4.00n/a9
Aug ’25€4.09
€5.75
+40.5%
29.2%€9.50€4.00n/a9
Jul ’25€4.26
€5.93
+39.2%
26.1%€9.50€4.00n/a10
Jun ’25€4.91
€5.93
+20.9%
26.1%€9.50€4.00n/a10
May ’25€5.02
€6.18
+23.1%
25.0%€9.50€4.00n/a10
Apr ’25€5.05
€6.25
+23.9%
24.0%€9.50€4.00n/a10
Mar ’25€5.20
€6.25
+20.3%
24.0%€9.50€4.00n/a10
Feb ’25€6.27
€6.51
+3.8%
17.7%€7.70€4.00n/a9
Jan ’25€6.31
€6.51
+3.1%
17.7%€7.70€4.00n/a9
Dec ’24€5.92
€6.72
+13.5%
15.8%€7.80€4.95n/a8
Nov ’24€6.05
€6.97
+15.2%
17.0%€8.20€5.00n/a8
Oct ’24€6.53
€7.64
+17.0%
14.8%€8.84€5.00€4.798
Sep ’24€7.27
€7.64
+5.2%
14.8%€8.84€5.00€4.778
Aug ’24€7.84
€7.71
-1.7%
14.7%€8.84€5.00€4.098
Jul ’24€7.44
€7.79
+4.7%
14.1%€8.84€5.00€4.269
Jun ’24€7.35
€7.99
+8.8%
13.7%€8.84€5.00€4.919
May ’24€7.71
€7.77
+0.8%
18.2%€9.00€5.00€5.0210
Apr ’24€7.92
€7.86
-0.7%
17.6%€9.00€5.00€5.0511
Mar ’24€8.40
€7.86
-6.4%
17.6%€9.00€5.00€5.2011
Feb ’24€9.11
€7.77
-14.7%
17.5%€9.00€5.00€6.2711
Jan ’24€9.13
€7.65
-16.1%
18.1%€9.00€5.00€6.3111
Dec ’23€8.49
€6.99
-17.7%
17.6%€8.50€5.00€5.9210
Nov ’23€7.40
€7.39
-0.1%
15.8%€9.00€5.00€6.0510
Oct ’23€7.16
€8.32
+16.2%
17.3%€10.90€5.60€6.5310

Analyst Forecast: Target price is more than 20% higher than the current share price, but analysts are not within a statistically confident range of agreement.


Discover undervalued companies